Benitec Biopharma Inc. (BNTC) vs Sagimet Biosciences Inc. (SGMT)
A side-by-side comparison of Benitec Biopharma Inc. and Sagimet Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNTC
Benitec Biopharma Inc.
$8.77HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
SGMT
Sagimet Biosciences Inc.
$8.75HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — BNTC vs SGMT
growth of $100 · dividends reinvested · last 3yBNTC +141.0% (+34.1%/yr)SGMT -43.4% (-17.3%/yr)BNTC compounded faster over this window
BNTC SGMT
BNTC vs SGMT: by the numbers
- •BNTC is the larger company ($301M vs $285M market cap).
Metrics side by side
Valuation
| Metric | BNTC | SGMT |
|---|---|---|
| P/B ratio | 1.70 | 1.11 |
Profitability
| Metric | BNTC | SGMT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -25.73% | -18.38% |
| ROIC | -28.88% | -20.40% |
Growth (annualized)
| Metric | BNTC | SGMT |
|---|---|---|
| Total return CAGR (5Y) | -31.08% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.